SAXENA PARAG
Insider CIK 1015823 · TZACU Chairman of the Board, Director, 10% owner · EUCR Chief Executive Officer, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RVPH REVIVA PHARMACEUTICALS HOL | A Award deriv | 2025-12-18 | 2025-12-19 | 8,200 | — | $0 | 8,200 | SEC↗ |
| RVPH REVIVA PHARMACEUTICALS HOL | A Award deriv | 2024-12-10 | 2024-12-12 | 8,200 | — | $0 | 8,200 | SEC↗ |
| RVPH REVIVA PHARMACEUTICALS HOL | J Other deriv | 2023-11-20 | 2023-11-22 | 585,366 | — | $0 | 585,366 | SEC↗ |
| RVPH REVIVA PHARMACEUTICALS HOL | J Other deriv | 2023-11-20 | 2023-11-22 | 585,366 | — | $0 | 585,366 | SEC↗ |
| RVPH REVIVA PHARMACEUTICALS HOL | A Award deriv | 2023-11-13 | 2023-11-14 | 8,200 | — | $0 | 8,200 | SEC↗ |
| RVPH REVIVA PHARMACEUTICALS HOL | A Award deriv | 2022-11-10 | 2022-11-14 | 3,900 | — | $0 | 3,900 | SEC↗ |
| RVPH REVIVA PHARMACEUTICALS HOL | P Buy deriv | 2022-09-08 | 2022-09-12 | 869,565 | $2.53 | $2.20M | 869,565 | SEC↗ |
| RVPH REVIVA PHARMACEUTICALS HOL | P Buy deriv | 2022-09-08 | 2022-09-12 | 513,834 | — | $0 | 513,834 | SEC↗ |
| RVPH REVIVA PHARMACEUTICALS HOL | P Buy deriv | 2022-09-08 | 2022-09-12 | 513,834 | $2.53 | $1.30M | 513,834 | SEC↗ |
| RVPH REVIVA PHARMACEUTICALS HOL | P Buy deriv | 2022-09-08 | 2022-09-12 | 869,565 | — | $0 | 869,565 | SEC↗ |
| RVPH REVIVA PHARMACEUTICALS HOL | A Award deriv | 2021-12-08 | 2021-12-10 | 5,300 | — | $0 | 5,300 | SEC↗ |
| RVPH REVIVA PHARMACEUTICALS HOL | A Award deriv | 2021-06-15 | 2021-06-16 | 4,000 | — | $0 | 4,000 | SEC↗ |
| RVPH REVIVA PHARMACEUTICALS HOL | P Buy deriv | 2021-06-01 | 2021-06-03 | 399,000 | — | $0 | 399,000 | SEC↗ |
| RVPH REVIVA PHARMACEUTICALS HOL | P Buy deriv | 2021-06-01 | 2021-06-03 | 931,000 | — | $0 | 931,000 | SEC↗ |
| RVPH REVIVA PHARMACEUTICALS HOL | P Buy | 2021-06-01 | 2021-06-03 | 399,000 | $3.75 | $1.50M | 399,000 | SEC↗ |
| RVPH REVIVA PHARMACEUTICALS HOL | P Buy | 2021-06-01 | 2021-06-03 | 931,000 | $3.75 | $3.49M | 931,000 | SEC↗ |
| RVPH REVIVA PHARMACEUTICALS HOL | J Other deriv | 2020-12-15 | 2020-12-28 | 540,500 | — | $0 | 0 | SEC↗ |
| RVPH REVIVA PHARMACEUTICALS HOL | A Award deriv | 2020-12-14 | 2020-12-28 | 197,500 | — | $0 | 540,500 | SEC↗ |
| RVPH REVIVA PHARMACEUTICALS HOL | J Other deriv | 2020-12-14 | 2020-12-28 | 343,000 | — | $0 | 343,000 | SEC↗ |
| RVPH REVIVA PHARMACEUTICALS HOL | A Award | 2020-12-14 | 2020-12-28 | 197,500 | — | $0 | 2,121,750 | SEC↗ |
| EUCR Eucrates Biomedical Acquis | J Other | 2020-11-24 | 2020-11-27 | 255,094 | — | $0 | 2,619,906 | SEC↗ |
| TZACU Tenzing Acquisition Corp. | P Buy | 2018-08-30 | 2018-09-04 | 33,000 | $10.00 | $330.0K | 1,924,250 | SEC↗ |
| TZACU Tenzing Acquisition Corp. | P Buy | 2018-08-23 | 2018-08-24 | 310,000 | $10.00 | $3.10M | 1,891,250 | SEC↗ |